Work

Genetics of Sleep - Sleep and Comorbidities - Connection at the Genetic Level

Year: 2013
Type: dissertation
Study design: Observational Study
Abstract: Sleep is a complex genetic trait with substantial heritability of up to 44%. Sleep problems are increasing in the society and the average sleep duration has been decreasing gradually during the past decades. At the same time the amount of cardiometabolic and psychiatric diseases has steadily increased. The common genetic variants contributing to sleep duration are largely unknown and we still do not know why we sleep. Recent advantages in genetics have provided the scientific community with the tools to elucidate the genes behind complex genetic traits as well. In this thesis, the traditional candidate gene approach as well as genome-wide tools combined with functional analysis were used to study the normal variation in sleep duration (I), consequences of sleep loss (I) and finally the connection of sleep with co-morbid diseases in humans (II-IV). Genetic variation behind normal sleep duration was studied using genome-wide association (GWAS) (I). The function of the variants was elucidated using RNA expression in population level. In addition, the variants that showed nominally significant association in the follow up sample were studied using RNA expression after experimentally induced sleep restriction (I). The original GWAS did not produce genome-wide significant findings. However, recent studies have shown that part of the association signals reaching only suggestive levels of association may be of biological relevance. We thus followed up the top 32 signals with suggestive evidence for association in a follow-up sample of 6834 individuals. Out of these, three SNPs with point wise P less than 0.05 associated with normal sleep duration. The SNPs were located near genes encoding for Krüppel like factor 6 (KLF6), protein tyrosine phosphatise receptor type U (PTPRU) and between centidin 1 (CENTD1) and protocadherin 7 (PCDH7). KLF6 variant associated with shorter sleep duration and KLF6 expression levels associated with shorter sleep duration. Accordingly, experimental sleep restriction increased KLF6 expression levels. Furthermore, the expression levels of KLF6 associated with increased slow wave sleep duration. This suggests that the variant in KLF6 may contribute to normal sleep duration via increased KLF6 expression and increased sleep intensity (I). However, the findings obtained from the GWAS should be interpreted with caution due to the relatively small number of individuals in the discovery data set and lack of genome-wide significant findings. The changes in the RNA expression after experimental sleep restriction revealed cellular activation of immune reaction and down regulation of cholesterol and lipid metabolism (I and unpublished). Sleep restriction may convey its proatherogenic effects via low grade inflammation and imbalance of metabolism, which previously have been related to cardiometabolic diseases. These changes may help to cope with short term sleep debt but are likely to induce pathological changes in the long term. In order to study the genetic connection of sleep duration with somatic diseases, the previously identified genome-wide significant variants associating with blood lipid levels were selected for association analysis with sleep duration. Two variants near Tribbles1 (TRIB1) associated with sleep duration independently from blood lipid levels (II). In addition, TRIB1 RNA expression levels were increased after experimental sleep restriction (II). The findings suggest that there are common genetic variants, such as those in TRIB1 that may regulate both sleep duration and blood lipid levels. The observations of shared genetic regulation both in RNA expression and in genetic level may partially explain why sleep duration is related to cardiovascular diseases. Finally, we evaluated the connection between psychiatric diseases and sleep. A common challenge when studying psychiatric phenotypes is the broad spectrum of disorders. In addition to the psychiatric diagnosis we studied endophenotypes such as insomnia, diurnal preference, seasonality and performance in cognitive tests and classified the study subjects in order to get a phenotypically, and also potentially a genetically more homogenous study population. One of the key molecules in homeostatic sleep regulation is adenosine. Its levels have recently also been related with depression. We found adenosine-related genetic polymorphisms that associated with depression (III). The findings suggest that the connection of sleep with psychiatric diseases may be partially explained by common genetic factors that mediate both sleep and psychiatric diseases. This hypothesis was further tested with patients suffering from bipolar disorder (BD). In BD, circadian stress such as jet lag or shift work can induce manic episodes. We thus tested if the same genetic variants associate with BD and with circadian and seasonal phenotypes as well as with cognitive task performance. We found variants in Cadherin 7 (CDH7) to associate with both sleep phenotypes and with BD. Interestingly, the variants predisposing to BD associated with better performance in visual processing, suggesting an evolutionary advantage for having the risk allele for BD. Together the findings suggest a shared genetic background for regulation of sleep with somatic and psychiatric disorders. It is important to identify the genetic factors contributing to sleep, together with somatic and psychiatric diseases. The knowledge of biological functions creates a strong basis for developing efficient treatments for sleep and psychiatric disorders.
Language: English
Open Access status: green
OpenAlex ID: W291432844
Cites: 274
Cited by: 1
Related to: 10